Q-Line Biotech Limited
NSE: QLINE
Q-Line Biotech Limited is an Indian listed company, traded under NSE: QLINE (ISIN INE1G2W01011).
It has a market capitalisation of ₹977 crore, a last close of ₹600.55 on 2026-10-19.
Valuation: a price-to-earnings ratio of 17.54x, a price-to-book ratio of 3.97x, a dividend yield of 0.0%.
Profitability: return on equity of 22.6%, return on capital employed of 26.4%, an operating margin of 28.7%.
Balance sheet and ownership: debt-to-equity of 0.92x, promoter holding of 67.5%.
| Metric | Value |
|---|---|
| Market capitalisation | 977 |
| Last close | ₹600.55 |
| P/E (TTM) | 17.54x |
| P/B | 3.97x |
| Dividend yield | 0.0% |
| ROE (FY) | 22.6% |
| ROCE (FY) | 26.4% |
| Operating margin (TTM) | 28.7% |
| Debt / equity | 0.92x |
| Promoter holding | 67.5% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means